Optimizing Preclinical Outsourcing

Venue: Hilton Boston Back Bay

Location: Boston, Massachusetts, United States

Event Date/Time: May 23, 2005 End Date/Time: May 25, 2005
Early Registration Date: Apr 29, 2005
Report as Spam


"As an industry segment, preclinical is growing. The increasing importance of innovative compounds discovered by small pharmas and biotechs as well as big pharma has led to many more products entering the preclinical development phase, fueling demand for specialized services. The FDA’s increased emphasis on safety testing, together with sponsors’ need to kill compounds as early as possible, demand more preclinical (or non-clinical) resources, capacity and specialized expertise. Continuous efforts to increase R & D productivity have resulted in a growth in preclinical services—and subsequently a growth in preclinical outsourcing to CROs and other specialized labs.
This new conference on Preclinical Outsourcing has been added to our portfolio to specifically address challenges surrounding:
- Evaluating internal capability and capacity and making the decision to outsource
- Selecting the best provider for your needs
- Balancing the priorities of cost, time and quality
- Satisfying timelines imposed by Clinical Operations (and if you are a small company—your investors)
- Meeting deadlines needed to progress your drug into clinical trials
- Communication breakdowns
- Maximizing the information needed to move your development program forward"